Ubiquinol as adjunctive therapy of heart failure

نویسنده

  • Stefan Siebrecht
چکیده

Today in industrialized countries cardiovascular diseases are the leading cause of death. In the U.S., a significant increase in the incidence of congestive heart failure (CHF) has been found in the recent years. Researchers at the Henry Ford “Heart and Vascular Institute” in Detroit observed that the annual number of heart failure cases has more than doubled in the period from 1989 to 2012. Although a variety of drugs for the therapy of cardiac disorders is available, there is still a high risk to find the optimal treatment. Nutrients that are needed by the heart have the advantage that they are very safe and can safely be given at all stages of heart disease. Therefore, the adjunctive nutrient therapy represents a good and safe way to optimize the therapy of heart patients. Nutrients are not intended to replace the traditional medicines and therapies but rather supplement it. A nutrient concomitant therapy may lead to a reduction of the dosage of classical drugs or, at best, it even can be omitted entirely sometimes. The use of nutrients in the context of an adjunctive therapy in heart disease should always be done in consultation with and under the supervision of the attending physician.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Ubiquinol (Reduced Coenzyme Q10): A novel yet ubiquitous nutrient for heart disease

Coenzyme Q10 (CoQ10) is a ubiquitous nutrient in human cells where it is essential for mitrochondrial energy production. CoQ10 exists in both an oxidized (ubiquinone) and reduced form (ubiquinol), with ubiquinol being the bioactive form. In addition to its use in cellular ATP production ubiquinol acts as a powerful lipid-soluble antioxidant that protects lipid membranes and lipoproteins from ox...

متن کامل

Myocardial energetics and ubiquinol in diastolic heart failure.

Diastolic heart failure, or heart failure with preserved ejection fraction, is a leading cause of morbidity and mortality. There are no current therapies effective in improving outcomes for these patients. The aim of this article is to review the literature and examine the role of coenzyme Q10 in heart failure with preserved ejection fraction related to mitochondrial synthesis of adenosine trip...

متن کامل

Randomized, Double Blind, Placebo Controlled Trial of Hydrosoluble Ubiquinol and Carnitine in Patients with Heart Failure: Longterm Follow up Results in the Tishcon Study

Background: Carnitine and coenzyme Q10 are important for myocardialmitochondrial function, and are deficient in patients with congestive heart failure. It is possible that supplementation with ubiquinol + lcarnitine may be protective among these patients, which may improve the quality of life and morbidity in heart failure. Subjects and Methods: In this controlled trial, the effects of carni Q-...

متن کامل

Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients.

Reduction of serum cholesterol levels with statin therapy decreases the risk of coronary heart disease. Inhibition of HMG-CoA reductase by statin results in decreased synthesis of cholesterol and other products downstream of mevalonate, which may produce adverse effects in statin therapy. We studied the reductions of serum ubiquinol-10 and ubiquinone-10 levels in hypercholesterolemic patients t...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2015